Drug Solubility in Luminal Fluids from Different Regions of the Small and Large Intestine of Humans.

Fadda, H. M., Sousa, T., Carlsson, A. S., Abrahamsson, B., Williams, J. G., Kumar, D. and Basit, A.W. (2010) Drug Solubility in Luminal Fluids from Different Regions of the Small and Large Intestine of Humans. Molecular Pharmaceutics, 7 (5). pp. 1527-1532. 10.1021/mp100198q.

Full text not available from this repository.

DOI: 10.1021/mp100198q


The purpose of this work was to study the solubility of two drugs with different physicochemical properties in luminal fluids obtained from various regions of the human gastrointestinal (GI) tract and to determine the most important luminal parameters influencing their solubility. Jejunal fluids were aspirated from healthy volunteers via an oral intubation tube. Ileal and colonic fluids were obtained from patients undergoing GI surgery. Stoma fluids were also retrieved from patients. pH and buffer capacity of all fluids were determined. Saturation solubility of prednisolone (unionisable) and mesalamine (5-aminosalicylic acid) (zwitterionic) was measured. Mean solubility of prednisolone in the different luminal fluids was 0.50 mg/mL (±0.05) and did not vary significantly between the different regions of the GI tract (ANOVA, p > 0.05). No correlation between prednisolone solubility and jejunal bile salt content was found. Mesalamine solubility increased down the GI tract: 1.97 (±0.25), 3.26 (±0.08), 6.24 (±1.13) and 7.95 (±0.21) mg/mL in jejunal, ileal, ascending and transverse/descending colonic fluids respectively. Buffer capacity also increased and in one patient was observed to range from 6.4 to 28.6 reaching 44.4 mM/L/pH unit in ileal, ascending and transverse/descending colon fluids respectively. Mesalamine solubility was found to be dependent on both buffer capacity and pH, with buffer capacity being the most important (standardized coefficient β = 0.849, p < 0.0001) compared to pH (β = 0.219, p < 0.05). For drugs delivered as modified release formulations it is important to consider solubility in different regions of the GI tract as significant differences can arise which will ultimately influence drug bioavailability.

Item Type:Article
Departments, units and centres:Department of Pharmaceutics > Department of Pharmaceutics
ID Code:1825
Journal or Publication Title:Molecular Pharmaceutics
Deposited By:Library Staff
Deposited On:26 Feb 2011 19:15
Last Modified:26 Feb 2011 19:15

Repository Staff Only: Item control page

School of Pharmacy Staff Only: Edit a copy to replace this item